131 related articles for article (PubMed ID: 18712176)
1. Interleukin-2 inhalation therapy in renal cell cancer: a case report and review of the literature.
Del Monte G; Ferroni P; Mariotti S; Fossile E; Guadagni F; Roselli M
In Vivo; 2008; 22(4):481-8. PubMed ID: 18712176
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and toxicity of gemcitabine combined vinorelbine on metastatic breast cancer: a report of 34 cases].
Zhou NN; Teng XY; Jiang WQ; Liu DG
Ai Zheng; 2007 Dec; 26(12):1373-6. PubMed ID: 18076805
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine in combination with vinorelbine for treatment of advanced breast cancer.
Hortobagyi GN
Clin Breast Cancer; 2002 May; 3 Suppl 1():34-8. PubMed ID: 12057044
[TBL] [Abstract][Full Text] [Related]
4. The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy.
Herbst RS; Khuri FR; Lu C; Liu DD; Fossella FV; Glisson BS; Pisters KM; Shin DM; Papadimitrakopoulou VA; Kurie JM; Blumenschein G; Kies MS; Zinner R; Jung MS; Lu R; Lee JJ; Munden RF; Hong WK; Lee JS
Cancer; 2002 Jul; 95(2):340-53. PubMed ID: 12124835
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine as prolonged infusion and vinorelbine in anthracycline and/or taxane pretreated metastatic breast cancer: a phase II study.
Schmid P; Heilmann V; Schulz CO; Dieing A; Lehenbauer-Dehm S; Jehn C; Sezer O; Possinger K; Flath B
J Cancer Res Clin Oncol; 2005 Sep; 131(9):568-74. PubMed ID: 16044345
[TBL] [Abstract][Full Text] [Related]
6. Biweekly triplet chemotherapy with gemcitabine, cisplatin and vinorelbine for advanced chemotherapy naïve non-small cell lung cancer.
Keskin S; Tas F; Ekenel M; Kilic L; Sen F; Yildiz I; Karabulut S; Ciftci R; Vatansever S
Tumori; 2013; 99(4):463-8. PubMed ID: 24326833
[TBL] [Abstract][Full Text] [Related]
7. Treatment of advanced breast cancer with gemcitabine and vinorelbine.
Hortobagyi GN
Oncology (Williston Park); 2001 Feb; 15(2 Suppl 3):15-7. PubMed ID: 11252883
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine combination chemotherapy in metastatic breast cancer: phase II experience.
O'Shaughnessy J
Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):15-21. PubMed ID: 14768400
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine and vinorelbine combination in patients with metastatic breast cancer.
Sanal SM; Gokmen E; Karabulut B; Sezgin C
Breast J; 2002; 8(3):171-6. PubMed ID: 12047474
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial.
Martín M; Ruiz A; Muñoz M; Balil A; García-Mata J; Calvo L; Carrasco E; Mahillo E; Casado A; García-Saenz JA; Escudero MJ; Guillem V; Jara C; Ribelles N; Salas F; Soto C; Morales-Vasquez F; Rodríguez CA; Adrover E; Mel JR;
Lancet Oncol; 2007 Mar; 8(3):219-25. PubMed ID: 17329192
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer.
Isokangas OP; Knuuttila A; Halme M; Mäntylä M; Lindström I; Nikkanen V; Viren M; Joensuu H; Mattson K
Ann Oncol; 1999 Sep; 10(9):1059-63. PubMed ID: 10572603
[TBL] [Abstract][Full Text] [Related]
12. Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Burris HA; Billings FT; Bradof JE; Baker M; Greco FA
Cancer; 2001 Nov; 92(9):2391-8. PubMed ID: 11745295
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of gemcitabine in combination with vinorelbine versus gemcitabine followed by vinorelbine for metastatic breast cancer.
Park IH; Ro J; Lee KS; Kim SN; Yun YH; Nam BH
Invest New Drugs; 2010 Oct; 28(5):659-69. PubMed ID: 19575146
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of gemcitabine and vinorelbine combination chemotherapy in patients with non-small-cell lung cancer not responding to previous chemotherapy.
Chen YM; Perng RP; Lee CS; Lin WC; Tsai CM; Whang-Peng J
Am J Clin Oncol; 2003 Dec; 26(6):567-70. PubMed ID: 14663373
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine Plus Vinorelbine as Second-Line Therapy in Patients With Metastatic Esophageal Cancer Previously Treated With Platinum-Based Chemotherapy.
Wang YS; Tian J; Han Y; Han SM; Shi SB
Oncol Res; 2016; 24(2):129-35. PubMed ID: 27296953
[TBL] [Abstract][Full Text] [Related]
16. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
[TBL] [Abstract][Full Text] [Related]
17. First-line chemotherapy with vinorelbine, gemcitabine, and carboplatin in the treatment of brain metastases from non-small-cell lung cancer: a phase II study.
Bernardo G; Cuzzoni Q; Strada MR; Bernardo A; Brunetti G; Jedrychowska I; Pozzi U; Palumbo R
Cancer Invest; 2002; 20(3):293-302. PubMed ID: 12025223
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant dose-dense gemcitabine plus docetaxel and vinorelbine plus epirubicin for operable breast cancer: improved prognosis in triple-negative tumors.
Medioni J; Huchon C; Le Frere-Belda MA; Hofmann H; Bats AS; Eme D; Andrieu JM; Oudard S; Lecuru F; Levy E
Drugs R D; 2011; 11(2):147-57. PubMed ID: 21679005
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients: a minnie pearl cancer research network phase II trial.
Hainsworth JD; Burris HA; Litchy S; Erland JB; Hon JK; Brierre JE; Greco FA
Cancer; 2000 Mar; 88(6):1353-8. PubMed ID: 10717616
[TBL] [Abstract][Full Text] [Related]
20. Is gemcitabine plus vinorelbine active in second-line chemotherapy of metastatic breast cancer? a single-center phase 2 study.
Rossi E; Perrone F; Labonia V; Landi G; Nuzzo F; Amabile G; Gridelli C; Di Maio M; D'Aiuto G; de Matteis A
Oncology; 2003; 64(4):479-80. PubMed ID: 12759551
[No Abstract] [Full Text] [Related]
[Next] [New Search]
